Your session is about to expire
← Back to Search
Early Adenotonsillectomy (eAT) for Sleep Apnea (PATS Trial)
PATS Trial Summary
This trial will test whether early adenotonsillectomy improves behavior, sleep-disordered breathing symptoms and quality of life for children who snore, but don't have obstructive sleep apnea.
- Sleep Apnea
PATS Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.PATS Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Is it possible for me to enroll in this clinical trial?
"459 minors aged between 3 and 12, who struggle with respiratory aspiration, have been accepted into this clinical trial. In addition to age criteria, participants must also satisfy the following conditions: Tonsillar hypertrophy ≥2 based on a standardized 0-4 scale; regular nocturnal snoring for at least three months that occurs more than half of sleep time on at least three nights per week; Polysomnogram (PSG) confirming an obstructive apnea index (OAI) <1/hour and apnea-hypopnea index (AHI) ≤3/hour without oxygen desaturation below 90"
Does this clinical trial accept participants who are beyond their mid-thirties?
"This particular trial is seeking patients in the 3-12 age range, while there are 46 trials for minors and 274 studies targeting seniors."
Are there any vacancies remaining in this research undertaking?
"As reflected on clinicaltrials.gov, this medical experiment is no longer accepting patients. It was initially posted on June 1st 2016 and edited most recently on July 18th 2022. Despite the closure of recruitment for this trial, there are still 337 other trials actively enrolling participants at present."
How many venues is this clinical experiment being conducted in currently?
"Currently, this clinical experiment is being carried out at 7 separate locations. These sites are located in Norfolk, Philadelphia and Ann Arbor with 4 other centres scattered across the country. It would be beneficial to select a local clinic to spare patients from long-distance travel should they choose to take part."
What aims is this clinical trial attempting to accomplish?
"The primary endpoint assessed over the course of a year is Change from baseline in Go-No-Go (GNG) signal detection parameter d'-prime. Secondary outcomes include GNG Continuous Performance Task (CPT) inhibitory control parameter d', Height, and BRIEF meta-cognition and emotional regulation summary scores and subscales.."
Share this study with friends
Copy Link
Messenger